Ceapro Inc. Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH and Provides Update on the Scale-Up Project for its Patented Pressurized Gas eXpanded (PGX) Technology

Grand News Network | November 7, 2023
  • PGX processing unit with a 10X (100 L) vessel capacity to be installed and tested at NATEX pilot testing facility in Austria
  • Yeast beta glucan (YBG) to be the first bio active to be processed at this location

EDMONTON, Alberta, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSXV:CZO, OTCQX: CRPOF)) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients and disruptive technologies for healthcare and cosmetic industries, announced today the signing of a technical collaboration with Austria-based NATEX Prozesstechnologie GmbH to accelerate the scale-up of its proprietary PGX Technology towards commercial level. The combination of Ceapro's natural ingredient processing expertise along with NATEX' deep knowledge of commercial high-pressure extraction equipment is providing a clear path to sustainable, large-scale production of PGX materials.

The signing of this agreement results from Ceapro's ongoing efforts to reduce time to market for PGX-processed materials. The sequential scale up path originally announced (from 10L to 50L and then 100L) has been revised to take place concurrently. Ceapro's ability to finalize specifications and test methods for high purity YBG has enabled PGX plant design to move forward with substantially fewer variables and less risk. Leveraging the fully defined YBG standard, a 50L plant is being installed and tested at Ceapro's existing facility in Edmonton instead of the University of Alberta. Pilot production at Ceapro's Edmonton facility is also taking advantage of the existing manufacturing site license for natural health products. Space at the University is being retained for other upcoming opportunities under discussion.

All ongoing advancements, along with NATEX' capability as a global leader in design, construction, and commissioning of high-pressure supercritical CO2 processing plants, is enabling the design and construction of the 100L plant in parallel with the 50L plant. 100L design and construction are underway at NATEX pilot testing facilities in Austria. The Austrian facility was selected since many components are already in place for supporting the PGX process. Furthermore, equipment purchased by Ceapro from a German facility prior to the pandemic has also been refurbished and is ready to ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner